<DOC>
	<DOCNO>NCT00035347</DOCNO>
	<brief_summary>A trial patient 18 year age hospitalize community acquire pneumonia otherwise eligible entry study randomly select receive one two treatment regimen . After write informed consent obtain , patient receive one follow two treatment regimen : 1 ) intravenous administration azithromycin ceftriaxone follow azithromycin tablet , 2 ) intravenous administration levofloxacin follow levofloxacin tablet . At least four study visit normally conduct approximately one month start therapy . The objective study compare safety efficacy two treatment regimen .</brief_summary>
	<brief_title>Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed Oral Azithromycin With Intravenous Levofloxacin Followed Oral Levofloxacin Treatment Moderate Severely Ill Hospitalized Patients With Community Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Patient must 18 year old . Patient must hospitalize require intravenous therapy treatment pneumonia . Patient must pneumonia document relevant sign symptom positive chest Xray . Patients certain underlying disease condition define study protocol . Pregnant woman , nurse mother , woman childbearing potential practicing adequate contraception . Known suspected hypersensitivity intolerance quinolone , penicillin , cephalosporin , macrolide antibiotic . Treatment systemic antibiotic 24 hour longer within 72 hour prior baseline visit . Subjects clinically significant renal dysfunction . Subjects clinically significant hepatic dysfunction . Subjects clinically significant cardiovascular disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>